vialroom

#semaglutide 2026-01-16

Friday35 messages8 participantstimes are UTC
Highlights from this day
  • taper_tess — this. week 68 results are not week 12 results 08:13
  • taper_tess — roughly, and these are means from different trials so dont read the last column as a race 09:22
  • VialBot — archive lookup: `STEP 1` appears in 214 logged lines across #semaglutide, #dosing-titration and #wins. earliest 2023-10-02. 10:15
FM

steady state is the bit people skip, judging a new dose after eight days tells you almost nothing

is there a reason to hold at 1.7 rather than going to 2.4

NH

dose day is sunday for me only because thats when i remember, not because sunday matters

NH

SELECT wasnt weight

janoshik-b-0114.pdf
2 pages · 627 KB · not retained in the public archive

SELECT was cardiovascular outcomes in people with overweight and existing disease, not a weight trial

TT

it ends the conversation about what the drug did in that trial. nothing else

Cited study
STEP 1 — once-weekly semaglutide 2.4 mg in adults with overweight or obesity
NEJM · 2021
68 weeks, placebo controlled, the one everybody cites
TT

68 weeks at 2.4mg weekly, mean weight change about -14.9% vs about -2.4% on placebo

SA

the spread is the bit nobody quotes. plenty of people well past 20 and plenty barely moved

SS

i was one of the barely moved ones for the first 4 months and then it went

SS

no i wasnt on 2.4 at 4 months, i was still climbing. thats sort of my point

the trial titrates over 16 weeks. people forget the first four months of the trial are also titration

SA

Cited study
STEP 8 — semaglutide 2.4 mg vs liraglutide 3.0 mg
JAMA · 2022
head to head, 68 weeks, weekly vs daily

which is why almost nobody in here talks about liraglutide anymore

SS

the daily injection was the killer for me honestly, not the mcg

*not the numbers. autocorrect

TT

roughly, and these are means from different trials so dont read the last column as a race

TrialDrug / doseWeeksMean weight change
STEP 1 (NEJM 2021)semaglutide 2.4 mg68about -15%
STEP 3 (JAMA 2021)sema 2.4 + intensive behavioural68about -16%
STEP 8 (JAMA 2022)semaglutide 2.4 mg68about -16%
STEP 8 (JAMA 2022)liraglutide 3.0 mg68about -6%
TT

yep. thats the uncomfortable finding and people skip past it

SA

different populations, different sites, you cannot subtract one trial from another

TE

worth saying out loud since @first_vial_finn is new — none of us are telling you what to take. this is just what got published and what happened to us

FV

understood, im just trying to get my head round the baseline before i decide anything

👍3
SS

214 and probably 200 of them are someone explaining that a mean is a mean